Nivolumab versus docetaxel in previously treated patients with advanced non-small-cell lung cancer: two-year outcomes from two randomized, open-label, phase III trials (CheckMate 017 and CheckMate 057) - Horn, Leora; Steins, Martin (Journal of clinical oncology, 2017)
Gesehen am 04.09.2018